BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 33663671)

  • 1. [Histone Deacetylase Inhibitors in the in Vitro Expansion of Hematopoietic Stem Cells].
    Chen M; Zhuang JL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Feb; 43(1):109-115. PubMed ID: 33663671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expansion and preservation of the functional activity of adult hematopoietic stem cells cultured ex vivo with a histone deacetylase inhibitor.
    Zimran E; Papa L; Djedaini M; Patel A; Iancu-Rubin C; Hoffman R
    Stem Cells Transl Med; 2020 Apr; 9(4):531-542. PubMed ID: 31950644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic and molecular signatures of cord blood CD34(+) cells treated with histone deacetylase inhibitors.
    Gajzer D; Ross J; Winder L; Navada S; Zhang W; Silverman L; Chaurasia P
    Vox Sang; 2016 Jan; 110(1):79-89. PubMed ID: 26084882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of epigenetic modifiers on the expansion and maintenance of human cord blood stem/progenitor cells.
    Mahmud N; Petro B; Baluchamy S; Li X; Taioli S; Lavelle D; Quigley JG; Suphangul M; Araki H
    Biol Blood Marrow Transplant; 2014 Apr; 20(4):480-9. PubMed ID: 24374212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylase inhibitors induce leukemia gene expression in cord blood hematopoietic stem cells expanded ex vivo.
    Lam YM; Chan YF; Chan LC; Ng RK
    Int J Hematol; 2017 Jan; 105(1):37-43. PubMed ID: 27531147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells.
    De Felice L; Tatarelli C; Mascolo MG; Gregorj C; Agostini F; Fiorini R; Gelmetti V; Pascale S; Padula F; Petrucci MT; Arcese W; Nervi C
    Cancer Res; 2005 Feb; 65(4):1505-13. PubMed ID: 15735039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylase 3 modulates the expansion of human hematopoietic stem cells.
    Elizalde C; Fernández-Rueda J; Salcedo JM; Dorronsoro A; Ferrin I; Jakobsson E; Trigueros C
    Stem Cells Dev; 2012 Sep; 21(14):2581-91. PubMed ID: 22455388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual roles of histone H3 lysine 9 acetylation in human embryonic stem cell pluripotency and neural differentiation.
    Qiao Y; Wang R; Yang X; Tang K; Jing N
    J Biol Chem; 2015 Jan; 290(4):2508-20. PubMed ID: 25519907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine hematopoietic stem cell dormancy controlled by induction of a novel short form of PSF1 by histone deacetylase inhibitors.
    Han Y; Gong ZY; Takakura N
    Exp Cell Res; 2015 Jun; 334(2):183-93. PubMed ID: 25933513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of histone deacetylase inhibitors in the aging of human umbilical cord mesenchymal stem cells.
    Wang Y; Chen T; Yan H; Qi H; Deng C; Ye T; Zhou S; Li FR
    J Cell Biochem; 2013 Oct; 114(10):2231-9. PubMed ID: 23564418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromatin-modifying agents promote the ex vivo production of functional human erythroid progenitor cells.
    Chaurasia P; Berenzon D; Hoffman R
    Blood; 2011 Apr; 117(17):4632-41. PubMed ID: 21355088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High dose of histone deacetylase inhibitors affects insulin secretory mechanism of pancreatic beta cell line.
    Yamato E
    Endocr Regul; 2018 Jan; 52(1):21-26. PubMed ID: 29453918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of the histone deacetylase inhibitors for the treatment of endometriosis: histone modifications as pathogenesis and novel therapeutic target.
    Kawano Y; Nasu K; Li H; Tsuno A; Abe W; Takai N; Narahara H
    Hum Reprod; 2011 Sep; 26(9):2486-98. PubMed ID: 21715447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of histone deacetylase inhibitor valproic acid on skeletal myocyte development.
    Li Q; Foote M; Chen J
    Sci Rep; 2014 Nov; 4():7207. PubMed ID: 25423891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ex Vivo Expansion of Adult Hematopoietic Stem and Progenitor Cells with Valproic Acid.
    Papa L; Djedaini M; Kintali M; Schaniel C; Hoffman R
    Methods Mol Biol; 2021; 2185():267-280. PubMed ID: 33165854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the antioxidant effects of different histone deacetylase inhibitors (HDACis) on human lens epithelial cells (HLECs) after UVB exposure.
    Qiu X; Rong X; Yang J; Lu Y
    BMC Ophthalmol; 2019 Feb; 19(1):42. PubMed ID: 30717701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sca-1 is an early-response target of histone deacetylase inhibitors and marks hematopoietic cells with enhanced function.
    Walasek MA; Bystrykh LV; Olthof S; de Haan G; van Os R
    Exp Hematol; 2013 Jan; 41(1):113-23.e2. PubMed ID: 22989761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex Vivo Expansion of Hematopoietic Stem Cells from Human Umbilical Cord Blood-derived CD34+ Cells Using Valproic Acid.
    Papa L; Djedaini M; Hoffman R
    J Vis Exp; 2019 Apr; (146):. PubMed ID: 31033947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproic acid enhances the engraftability of human umbilical cord blood hematopoietic stem cells expanded under serum-free conditions.
    Seet LF; Teng E; Lai YS; Laning J; Kraus M; Wnendt S; Merchav S; Chan SL
    Eur J Haematol; 2009 Feb; 82(2):124-32. PubMed ID: 19067743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the anticancer properties of a novel valproic acid prodrug to leading histone deacetylase inhibitors.
    Tarasenko N; Chekroun-Setti H; Nudelman A; Rephaeli A
    J Cell Biochem; 2018 Apr; 119(4):3417-3428. PubMed ID: 29135083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.